Gambia vs Zambia: Cause of death, by non-communicable diseases, ages 15-59, male
Gambia
34.6%
in 2021
Zambia
33.7%
in 2021
Gambia rank
157th
Zambia rank
159th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Gambia
- Zambia
How they compare
Gambia currently reports 34.6% against 33.7% in Zambia, a difference of 0.9%.
Across all 6 years both countries report, Gambia has been ahead every year.
Gambia ranks 157th and Zambia ranks 159th of 185 countries.
Gambia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40.0% | 14.0% | 26.1% | Gambia |
| 2010s | 38.9% | 28.4% | 10.5% | Gambia |
| 2020s | 36.7% | 33.3% | 3.4% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Gambia or Zambia?
- Gambia, at 34.6% against 33.7% in Zambia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Gambia and Zambia?
- 0.9%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Zambia?
- 6 years are reported by both, from 2000 to 2021.
- How do Gambia and Zambia rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Gambia ranks 157th and Zambia ranks 159th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.